To determine whether IL-33 directly drives macrophages toward the M2 phenotype in humans, we treated monocytes isolated from PBMCs of patients with IBD with granulocyte macrophage-colony stimulating factor (GM-CSF) for 72 h and then with hrIL-33. This evidence concerns the gene CSF2 and inflammatory bowel disease.